Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
ConditionPreeclampsia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMedical College of Wisconsin
About this trial
The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.
Eligibility criteria
Qualifiers
Pregnant patients at gestational age <= 16 weeks
Live, non-anomalous gestation
Normotensive at enrollment
Meet criteria consistent with 'moderate' to 'high' risk for preeclampsia based on ACOG/USPSTF guidelines for low-dose aspirin administration to prevent hypertensive disorders of pregnancy
Disqualifiers
Multiple gestation
Chronic (pregestational hypertension)
Inability of unwillingness to provide informed consent
Active suicidality or psychosis
Trial design
Treatments tested in this trial
- Mindfulness training
- Garmin Vivoactive 4 watch
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov